How many days of Augmentin (amoxicillin-clavulanate) should be prescribed for a patient with a nasal pack (nasal tamponade) for epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a patient with a nasal pack for epistaxis, a 5-day course of Augmentin (amoxicillin-clavulanate) is typically recommended, as the packing should generally not remain in place for more than 5 days to minimize infection risk 1.

Key Considerations

  • The duration of antibiotic prophylaxis should align with the recommended duration of nasal packing, which is typically no longer than 5 days 1.
  • The standard adult dosage of Augmentin is 875 mg amoxicillin/125 mg clavulanate twice daily, or 500 mg amoxicillin/125 mg clavulanate three times daily.
  • Antibiotic prophylaxis is given to prevent toxic shock syndrome and other infectious complications while the nasal packing remains in place.
  • It's essential to weigh the benefits and risks of antibiotic use, considering the potential for allergic reactions and gastrointestinal problems 1.

Important Reminders

  • Patients should avoid straining, lifting over 10 pounds, bending over, and exercising to minimize the risk of further bleeding.
  • Sleeping with the head slightly elevated may also help reduce bleeding risk.
  • Patients should not try to blow their nose if they have packing in place and should sneeze with their mouth open if necessary.
  • Any concerning symptoms, such as return of blood from the nose or mouth, fever over 101°F, or increasing pain, should be reported to the clinician promptly 1.

From the Research

Nasal Packing and Antibiotic Use for Epistaxis

  • The use of prophylactic antibiotics with nasal packing for epistaxis has been a topic of debate, with varying practices among healthcare professionals 2, 3, 4.
  • Studies have shown that the rate of infection in patients with nasal packing for epistaxis is low, suggesting that prophylactic antibiotics may not be necessary 2, 3, 5.
  • A systematic review and meta-analysis found that the proportion of clinically significant infections in patients with anterior nasal packing was 0.8%, resulting in a number needed to treat of 571 to prevent one infection 3.
  • A survey of otolaryngologists found that antibiotic prescription rates varied based on packing type, with 20.0% prescribing antibiotics for dissolvable packing and 84.2-84.6% for nondissolvable packing 4.
  • The same survey found that 69.7% of respondents stopped antibiotics immediately following packing removal, and 85.6% cited the risk of toxic shock syndrome as a reason for prescribing antibiotics 4.

Duration of Antibiotic Use

  • There is limited evidence to support the use of prophylactic antibiotics for a specific duration in patients with nasal packing for epistaxis.
  • One study found that 69.7% of otolaryngologists stopped antibiotics immediately following packing removal, suggesting that a short course of antibiotics may be sufficient 4.
  • However, the optimal duration of antibiotic use in this setting is unclear, and further studies are needed to determine the most effective and safe approach 2, 3, 5.

Specific Antibiotics Used

  • Amoxicillin-clavulanate (Augmentin) is a commonly used antibiotic for prophylaxis in patients with nasal packing for epistaxis 4.
  • However, the choice of antibiotic and duration of use should be individualized based on patient factors and local resistance patterns 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.